Loading…

Bridge Functionalisation of Bicyclo[1.1.1]pentane Derivatives

“Escaping from flatland”, by increasing the saturation level and three‐dimensionality of drug‐like compounds, can enhance their potency, selectivity and pharmacokinetic profile. One approach that has attracted considerable recent attention is the bioisosteric replacement of aromatic rings, internal...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie International Edition 2021-11, Vol.60 (47), p.24754-24769
Main Authors: Anderson, Joseph M., Measom, Nicholas D., Murphy, John A., Poole, Darren L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:“Escaping from flatland”, by increasing the saturation level and three‐dimensionality of drug‐like compounds, can enhance their potency, selectivity and pharmacokinetic profile. One approach that has attracted considerable recent attention is the bioisosteric replacement of aromatic rings, internal alkynes and tert‐butyl groups with bicyclo[1.1.1]pentane (BCP) units. While functionalisation of the tertiary bridgehead positions of BCP derivatives is well‐documented, functionalisation of the three concyclic secondary bridge positions remains an emerging field. The unique properties of the BCP core present considerable synthetic challenges to the development of such transformations. However, the bridge positions provide novel vectors for drug discovery and applications in materials science, providing entry to novel chemical and intellectual property space. This Minireview aims to consolidate the major advances in the field, serving as a useful reference to guide further work that is expected in the coming years. This Minireview summarises the known chemistry for the preparation of bicyclo[1.1.1]pentane (BCP) derivatives reported up to mid‐2021. Bridge substitution on BCP derivatives often provides patent‐free, novel vectors for substituent disposition in drug discovery and materials science; this capacity may prove to be transformational in the coming years.
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.202106352